ARID2 and nonpapillary renal cell carcinoma: Specifically, we found PBAF complex mutations to be most common in ccRCC tumors which were dominated by PBRM1 mutations; interrogation of this cohort of ICB-treated ccRCC patients failed to reveal an association between PBRM1/ARID2 mutations and overall survival or time-to-treat failure.